19th Congress of the European Society for Dermatology and Psychiatry (ESDaP) and 2nd Brain Skin Colloquium Conference (BSC), June 11–13, 2021, London
DOI:
https://doi.org/10.2340/actadv.v101.872Keywords:
psychodermatology, psychocutaneous medicine, quality of life, psychosocial co-morbiditiesAbstract
The Congress of the European Society for Dermatology and Psychiatry (ESDaP), held in conjunction with the 2nd Brain Skin Colloquium (BSC) Conference, hosted over 60 speakers delivering 47 oral presentations, 41 poster presentations and 5 keynote talks via 2 simultaneous livestream platforms. The 2-day conference, held biennially, was due to be hosted in London, but was converted to a virtual format due to the Covid-19 pandemic. This report presents a synopsis of the conference.
Downloads
References
Dalgard F. Characteristics of patients seen at a psychodermatology unit in Sweden. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Jafferany M. Depression and Psoriasis: How to Diagnose and manage. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Bullmore E. Inflammation and depression. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Griffiths C. Insights into the Brain-Skin Axis. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Kirby B. Psoriasis and Mindfulness. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Yosipovitch G. Mechanisms of Itch and Its Management. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.
Misery L. Pruriplastic Itch, An Equivalent of Nociplastic Pain. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.
McGlone F. The Skin's Protectors: The 3 C's. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home
Evers A. Nocebo effects on itch as possible predictor of itch sensitization. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Thompson A. Lack of mental health support for UK skin disease patients: The 2020 All Party Parliamentary Group on Skin's report. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Finlay A. Family impact: the hidden burden revealed by FROM-16. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.
Bundy C. Structured Psychological Support for Dermatology Patients and Adaptations During the SARS-CoV-2 Pandemic. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Flohr C. COVID-19 in AD: lessons from the SECURE-AD physician and patient registries. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.
Cooper C. Wellbeing in the workplace. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.
Poot F, Sampogna F, Tomas-Aragones L & Gieler U. The psychodermatology diploma: comparing the online versus the face-to-face experience. Br J Dermatol 2021; 185: e86.
Ahmed A. Single-centre experience of setting up a psychodermatology clinic: making the most of what you have. Br J Dermatol 2021; 185: e83.
Capdevila P, Lopez-Trujillo E, Tribo MJ & Pujol RM. Psychopathological profile and responseto combined therapy with mirtazapine and sertraline in patients with somatoform pruritus. Br J Dermatol 2021; 185: e74.
Schmidt LEM, Merdha L, Lang V, Preis S, Bleuel R, Schuch A et al. A qualitative study on maternal attachment behaviour as a risk factor for the onset of atopic dermatitis in theinfant. Br J Dermatol 2021; 185: e73.
Day M, Heapy C, Norman P, Emerson LM, Murphy R & Thompson A . Impact of childhood psoriasis on children and parents: an interpretative phenomenological analysis. Br J Dermatol 2021; 185: e71.
Birkjær M, Thomsen SF, Cernica C, Bewley A & Bainton A. Using life evaluation to revise the Dermatology Life Quality Index: a multinational survey of patients with psoriasis. Br J Dermatol 2021; 185: e70.
Krajewski P, Matusiak Ł, von Stebut E, Schultheis M, Kirschner U, Nikolakis G et al. Decrease in quality of life among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients. Br J Dermatol 2021; 185: e77.
https://doi.org/10.3390/life11010034 DOI: https://doi.org/10.3390/life11010034
Rachael P, Rachael H, Trialonis-Suthakharan N, Chachos E, Augustin M & Bundy C. Defining, understanding and measuring the impact of dermatological conditions on patients' lives: a qualitative concept elicitation study for a new patient-reported impact of dermatological disease (PRIDD) measure. Br J Dermatol 2021; 185: e83.
Hewitt R, Pattinson R, Cordingley L, Griffiths C, Kleyn E, McAteer H et al. Implementation of the PsoWellTM model for the management of people with complex psoriasis. Br J Dermatol (in Press). Br J Dermatol 2021; 185: e72.
https://doi.org/10.2340/00015555-3802 DOI: https://doi.org/10.2340/00015555-3802
Lander K, Harris C, Al-Attar A & Kleyn E. Eczema and interpersonal avoidance. Br J Dermatol 2021; 185: e73.
Brookes T S-R, Barlow R, Mohandas P & Bewley A. Topical steroid withdrawal: an emerging clinical problem. Br J Dermatol 2021; 185: e74.
Tanev T. Social media and self-perception: a psychodermatological perspective. Br J Dermatol 2021; 185: e87.
Schut C, Dalgard FJ, Bewley A, Evers AWM, Gieler U, Lien L et al. Prevalence of symptoms of body dysmorphic disorder in patients with dermatological conditions compared to healthy skin controls: results of the ESDAP-study-II. Br J Dermatol 2021; 185: e81.
Al-Sarraf A, Bewley A & Corazza O. Skin tone lightening: a psychodermatological problem? Br J Dermatol 2021; 185: e76.
Bewley A, Thyssen JP, Chiu WS, Rojo R, Biswas P, Feeney C et al. Impact of abrocitinib on itch, sleep, skin pain and psychological stress in patients with moderate-to-severe atopic dermatitis: pooled analysis from JADE monotherapy trials. Br J Dermatol 2021; 185: e72.
Shinhmar S, Lawrence L & Bewley A. The impact of the COVID-19 pandemic on psychodermatology patients. Br J Dermatol 2021; 185: e90.
Walsh C, Leavey G & McLaughlin M. Informing the development of a Needs Assessment Tool for Ichthyosis Caregivers (NAT-IC): an international multimethod qualitative study using framework analysis. Br J Dermatol 2021; 185: e79.
Barlow R, Payyazhi G, Hogan S, Grindlay D, Verma M, Choi D et al. Suicide and suicidality in children and adolescents with chronic skin disorders: a systematic review. Br J Dermatol 2021; 185: e97.
Lada G, Talbot PS, Chinoy H, Warren RB & Kleyn CE. Clinical correlates of depression and anxiety in psoriasis and prevalence of undiagnosed depression. Br J Dermatol 2021; 185: e71.
Williams P & Dimitrov D. Suicide: last resort for the prisoners trapped in ill skin. Br J Dermatol 2021; 185: e76.
Shatokhina E, Kruglova L & Polonskaia A. Efficacy of dupilumab in patients with immune checkpoint inhibitor-related pruritus. Br J Dermatol 2021; 185: e101.
Moschogianis S, Chisholm A, McKie S, Griffiths C, Elliott R & Kleyn E. Towards an understanding of the psychosocial impact of psoriasis. Br J Dermatol 2021; 185: e103.
Fellows JL, Harper N, Mortimer H & Goulding JMR. Potential utility of eye movement desensitization and reprocessing and the flash technique in psychodermatology. Br J Dermatol 2021; 185: e104.
Published
How to Cite
License
Copyright (c) 2021 Anthony Bewley, Richard Barlow, Alia Ahmed, Padma Mohandas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
